Stocks Comparison
Cardiff Lexington vs Oncology Institute: revenue, profit, margins and growth compared
Cardiff Lexington brought in $11.5M of revenue in fiscal 2025, Oncology Institute $502.7M in fiscal 2025. Revenue changed by +39.5% at Cardiff Lexington and +27.8% at Oncology Institute on the year before, so Cardiff Lexington grew faster. Cardiff Lexington kept -47.7% of its revenue as net profit, Oncology Institute -12.1%.
Side by side, latest fiscal year
| CDIX | TOI | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $11.5M | $502.7M |
| Revenue growth | +39.5% | +27.8% |
| Net income | -$5.5M | -$60.6M |
| Net margin | -47.7% | -12.1% |
| Free cash flow | n/a | -$27.8M |
| Free cash flow margin | n/a | -5.5% |
| Earnings per share (diluted) | n/a | -$0.54 |
| Cash | $318.5K | $33.6M |
| Debt | $18.6M | $77.4M |
| Price to earnings | n/a | n/a |
| Market value | $6.6M | $522.8M |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #508 of 742 · Health care | #204 of 742 · Health care |
Over the years
Questions about Cardiff Lexington and Oncology Institute
Which is bigger by revenue, Cardiff Lexington or Oncology Institute?
Oncology Institute is bigger by revenue: $502.7M in fiscal 2025, against $11.5M for Cardiff Lexington in fiscal 2025.
Which keeps more of its revenue as profit, Cardiff Lexington or Oncology Institute?
Cardiff Lexington had a net margin of -47.7% in fiscal 2025; Oncology Institute had -12.1% in fiscal 2025.
Which grew revenue faster, Cardiff Lexington or Oncology Institute?
In their latest fiscal years revenue changed by +39.5% at Cardiff Lexington and +27.8% at Oncology Institute.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.